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Background
Oligomannose sugars on gp120 are of significance to HIV
vaccine design because of the description of the broadly
neutralizing mAb 2G12 and, more recently, of the potent
and broadly neutralizing ‘PGT’ series of mAbs, which bind
with high affinity to clusters of oligomannose moieties on
gp120. Attempts to elicit oligomannose-specific antibodies
have focused mainly on immunizing with antigenic clus-
ters of synthetic oligomannose or natural oligomannose.
These strategies have had limited success, suggesting that
alternative approaches are needed. Here, we present the
surface lipo-oligosaccharide (LOS) of Rhizobium radiobac-
ter Rv3 that antigenically mimics the 2G12 epitope, as one
potential new avenue of exploration.
Methods
The chemical structure of the Rv3 OS was determined by
NMR and its antigenic similarity to the 2G12 epitope
determined by ELISA and X-ray crystallography. Immuno-
genicity of the Rv3 OS and its ability to elicit antibodies of
2G12-like specificity was assessed by immunizing mice
with heat-killed Rv3 bacteria.
Results
The detailed chemical analysis of the Rv3 OS revealed that
its carbohydrate backbone consists of a unique tetraman-
nose backbone that is analogous to the D1 arm of mam-
malian oligomannose. 2G12 bound with at least similar
affinity to purified Rv3 OS as reported for oligomannose.
The 2.4 Å-structure of the 2G12:Rv3 OS complex shows
that 2G12 contacts all four mannosyl moieties in the Rv3
backbone that mimic the D1 arm, with the majority of
contacts occurring with the terminal mannose disacchar-
ide. Antibodies elicited by immunizing with heat-killed
bacteria bound a synthetic tetramannose epitope and
monomeric gp120.
Conclusion
Although the elicited antibodies failed to exhibit the
desired neutralizing activity, our data suggest that presen-
tation of an antigenic analog of mammalian oligomannose
in a bacterial context presents a novel avenue for pursuing
immunogens to elicit oligomannose-specific HIV neutra-
lizing antibodies. The development of Rv3-based bioconju-
gates using human carbohydrate vaccine carriers is
ongoing.
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